156 related articles for article (PubMed ID: 22965839)
21. The upregulation of cystatin C in oral submucous fibrosis.
Chung-Hung T; Shun-Fa Y; Yu-Chao C
Oral Oncol; 2007 Aug; 43(7):680-5. PubMed ID: 17070095
[TBL] [Abstract][Full Text] [Related]
22. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
Oral Oncol; 2005 Oct; 41(9):940-6. PubMed ID: 16054426
[TBL] [Abstract][Full Text] [Related]
23. Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels.
Tsai CH; Yang SF; Chen YJ; Chu SC; Hsieh YS; Chang YC
Oral Dis; 2004 Nov; 10(6):360-4. PubMed ID: 15533212
[TBL] [Abstract][Full Text] [Related]
24. The upregulation of heat shock protein 70 expression in areca quid chewing-associated oral squamous cell carcinomas.
Lee SS; Tsai CH; Ho YC; Chang YC
Oral Oncol; 2008 Sep; 44(9):884-90. PubMed ID: 18234541
[TBL] [Abstract][Full Text] [Related]
25. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chen YJ; Chang YC
Oral Dis; 2007 Mar; 13(2):234-8. PubMed ID: 17305628
[TBL] [Abstract][Full Text] [Related]
26. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
27. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
Yu CC; Liao YW; Yu CH; Chang YC
J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
[TBL] [Abstract][Full Text] [Related]
28. The expression of O(6) -methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline.
Lee SS; Tsai CH; Yu CC; Ho YC; Hsu HI; Chang YC
J Oral Pathol Med; 2013 Sep; 42(8):600-5. PubMed ID: 23278137
[TBL] [Abstract][Full Text] [Related]
29. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
30. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
31. Thrombin-stimulated connective tissue growth factor (CTGF/CCN2) production in human buccal mucosal fibroblasts: Inhibition by epigallocatechin-3-gallate.
Chang JZ; Yang WH; Deng YT; Chen HM; Kuo MY
Head Neck; 2012 Aug; 34(8):1089-94. PubMed ID: 21953860
[TBL] [Abstract][Full Text] [Related]
32. Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors.
Thangjam GS; Agarwal P; Balapure AK; Rao SG; Kondaiah P
J Periodontal Res; 2009 Dec; 44(6):736-43. PubMed ID: 19438976
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts.
Chang YC; Hu CC; Tseng TH; Tai KW; Lii CK; Chou MY
J Oral Pathol Med; 2001 Sep; 30(8):458-64. PubMed ID: 11545236
[TBL] [Abstract][Full Text] [Related]
34. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.
Chen CC; Huang JF; Tsai CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):604-14. PubMed ID: 7490793
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
[TBL] [Abstract][Full Text] [Related]
36. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
[TBL] [Abstract][Full Text] [Related]
37. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
[TBL] [Abstract][Full Text] [Related]
38. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
[TBL] [Abstract][Full Text] [Related]
39. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
